MDMA — more commonly known as ecstasy — is one step closer to becoming a legal form of treatment for post-traumatic stress disorder (PTSD) in the United States.
Researchers have for years been looking at how the drug could be used in conjunction with therapy to help sufferers confront their trauma.
Now the Food and Drug Administration (FDA) has approved it for use in a phase-three clinical trial — the final stage of research required before it can be considered for approval as a prescription drug.
So, what exactly is MDMA, what will the clinical trial involve and what implications might it have for sufferers in Australia?
Read more here: http://www.abc.net.au/news/2016-12-01/how-might-mdma-be-used-to-treat-post-traumatic-stress-disorder/8082620